Targeting prostate cancer stem-like cells by an immunotherapeutic platform based on immunogenic peptide-sensitized dendritic cells-cytokine-induced killer cells

BACKGROUND: Autologous cellular immunotherapy or immune enhancement therapy has demonstrated some promising benefits for prostate cancer. T cell-based immunotherapy or sipuleucel-T therapy has yielded certain beneficial responses and a slight improvement on the overall survival of patients with meta...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhu, Li, Youjia, Wang, Yuliang, Wu, Dinglan, Lau, Alaster Hang Yung, Zhao, Pan, Zou, Chang, Dai, Yong, Chan, Franky Leung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7079411/
https://www.ncbi.nlm.nih.gov/pubmed/32183880
http://dx.doi.org/10.1186/s13287-020-01634-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7079411/
https://www.ncbi.nlm.nih.gov/pubmed/32183880
http://dx.doi.org/10.1186/s13287-020-01634-6

Ejemplares similares